Why the study?
Does low-dose oral anticoagulation with INR self-management increase the risk of thrombo-embolic events compared to conventional dose INR self-management in patients with mechanical heart valve prostheses?
Population
Patients with mechanical heart valve prostheses
Comparison
Low-dose oral anticoagulation with INR… vs Conventional dose oral anticoagulation with INR…
Design
RCT
Authors
Loading...
Supports low-dose INR self-management in mechanical valves; extends RCT evidence for reduced-intensity targets.
Does low-dose oral anticoagulation with INR self-management increase the risk of thrombo-embolic events compared to conventional dose INR self-management in patients with mechanical heart valve prostheses?
Low-dose INR self-management in patients with mechanical heart valves does not increase thrombo-embolic risk compared to conventional dosing, though bleeding remains the predominant risk.
Koertke et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: